Latest Medical Mergers & Acquisitions in the U.S. 🏥💼
Bristol-Myers Squibb & Mirati Therapeutics 🤝💊
Details: Bristol-Myers Squibb, headquartered in the United States, is acquiring Mirati Therapeutics, also based in the U.S., in a deal valued at approximately $4.8 billion. This acquisition aims to enhance Bristol-Myers Squibb’s oncology portfolio with Mirati’s advanced cancer therapies. Mirati, known for its innovative treatments targeting specific cancer mutations, complements Bristol-Myers Squibb's existing pipeline, focusing on precision medicine in oncology.
Eli Lilly & DICE Therapeutics 💉🔬
Details: Eli Lilly, a global pharmaceutical company based in the U.S., has acquired DICE Therapeutics, a biotechnology firm also located in the U.S., for around $2.4 billion. DICE Therapeutics specializes in developing therapies for autoimmune and inflammatory diseases. This acquisition is set to strengthen Eli Lilly’s research and development capabilities in these areas, enhancing its pipeline with DICE’s specialized treatments and reflecting Eli Lilly's commitment to advancing immunological therapies.
Cleveland Clinic & Medtronic 🏥💓